$10.240
-0.244 (-2.38%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DSGN Prediction & Forecast by Similar Chart Analysis
Alphio's DSGN stock price prediction model matches the current Design Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.34 (+0.96%). The 1-week path is $10.17 (-0.65%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Design Therapeutics Inc Stock?
Design Therapeutics Inc is a good buy right now due to its current price of $10.24, which is significantly lower than the analyst price target of $26 from Wells Fargo, indicating a potential upside of 154%. Additionally, the company has a strong cash position of $207.4 million, which supports its ongoing R&D efforts and clinical trials. The main risk is the negative EPS forecast of -0.38 for the next earnings date on November 4, 2026, which could impact short-term sentiment.
DSGN stock price ended at $10.24 on Friday, after losing -2.38%
Design Therapeutics Inc (DSGN) last closed at $10.24, losing -2.38%. These facts feed the 1-day and 1-week DSGN price prediction above.
Forecast Drivers
Design Therapeutics Inc (DSGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches DSGN, ranked by similarity.
Seasonality analysis for DSGN
Historically the probability of a positive October return for DSGN is 85.71%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for DSGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.35 | $3.92 | $3.95 | -61.74% |
| Nov 2026 | $3.35 | $3.55 | $4.43 | -65.31% |
| Dec 2026 | $2.65 | $3.55 | $4.07 | -65.31% |
In 2026, Design Therapeutics Inc (DSGN) is projected to range from $2.65 to $4.43.
Design Therapeutics Inc 2026 monthly forecast
In Oct 2026, Design Therapeutics Inc is projected to average $3.92, with a low of $3.35 and high of $3.95.
In Nov 2026, Design Therapeutics Inc is projected to average $3.55, with a low of $3.35 and high of $4.43.
In Dec 2026, Design Therapeutics Inc is projected to average $3.55, with a low of $2.65 and high of $4.07.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.